Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_provenance.
- befree-2016 importedOn "2016-02-19" NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_provenance.
- NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_assertion wasGeneratedBy ECO_0000203 NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_provenance.
- NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_assertion wasDerivedFrom befree-2016 NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_provenance.
- NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_assertion SIO_000772 22303460 NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_provenance.
- NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_assertion evidence source_evidence_literature NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_provenance.
- NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_assertion description "[Herein, we report the Tregs-targeting and immune-promoting effect of a class I specific HDAC inhibitor, entinostat, in combination with either IL-2 in a murine renal cell carcinoma (RENCA) model or a survivin-based vaccine therapy (SurVaxM) in a castration resistant prostate cancer (CR Myc-CaP) model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP958422.RA5fMyllThk4pDZvAN-1ZKeIL9YdmBfA1PQEQGCymB3H0130_provenance.